gp100 (639-647)

gp100 (639-647) is a synthetic peptide fragment derived from the melanoma-associated antigen gp100, specifically encompassing amino acids 639 to 647 of the native protein sequence. As a well-characterized epitope, it is widely recognized for its immunological relevance, particularly in studies investigating antigen-specific T cell responses and tumor immunology. The peptide's defined sequence and precise length make it an essential tool for probing peptide-MHC interactions, enabling detailed mechanistic studies of immune recognition and cellular signaling. Its utility extends across a range of experimental platforms, supporting both fundamental research and the development of immunological assays targeting melanoma and related biological processes.

Epitope mapping: Researchers employ gp100 (639-647) in epitope mapping experiments to delineate the specific regions of the gp100 antigen recognized by cytotoxic T lymphocytes (CTLs). By utilizing this defined peptide, investigators can assess T cell specificity, identify immunodominant regions, and characterize the fine specificity of T cell receptors. Such studies are critical for understanding the molecular basis of antigen recognition and for guiding the design of immunotherapeutic strategies targeting melanoma antigens.

T cell activation assays: The peptide serves as a robust reagent for in vitro stimulation of antigen-specific T cells, particularly in the context of HLA-A2-restricted responses. It is frequently used to pulse antigen-presenting cells, such as dendritic cells or peripheral blood mononuclear cells, facilitating the activation and expansion of gp100-specific CTLs. These assays enable the functional assessment of T cell responses, cytokine production, and cytotoxic activity, providing key insights into immune dynamics and the evaluation of immunomodulatory interventions.

Peptide-MHC binding studies: gp100 (639-647) is instrumental in biochemical and structural analyses of peptide-MHC class I interactions. By studying its binding affinity and stability with specific HLA alleles, researchers can elucidate the molecular determinants governing antigen presentation. Such investigations contribute to the optimization of peptide-based vaccine candidates and inform the selection of epitopes with favorable immunogenic properties for translational research.

Immunomonitoring: In translational and preclinical research, the peptide is widely utilized as a reference antigen for monitoring immune responses in samples from experimental models or human donors. Techniques such as ELISPOT, intracellular cytokine staining, and tetramer staining rely on this peptide to detect and quantify antigen-specific T cells. The use of a well-defined epitope ensures reproducibility and accuracy in tracking immune responses during vaccine development, immunotherapy evaluation, and longitudinal studies of immune memory.

Peptide synthesis and assay development: gp100 (639-647) also finds application as a model substrate in the optimization of peptide synthesis protocols and the development of peptide-based immunoassays. Its defined sequence and immunological relevance make it a preferred choice for validating synthetic methodologies, calibrating assay sensitivity, and benchmarking analytical platforms designed for peptide detection or quantification. These uses support the advancement of peptide chemistry and the generation of high-quality reagents for immunological research.

1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

2. Myotropic activity of allatostatins in tenebrionid beetles

3. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

4. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

5. The spatiotemporal control of signalling and trafficking of the GLP-1R